Coulter Partners secures Chief Technology Officer for Basilea Pharmaceutica International Ltd.
“We are very pleased that Dr. Gerrit Hauck has assumed the role of Chief Technology Officer at Basilea and thank the team at Coulter Partners for their outstanding professional work in helping us to achieve this appointment. Dr. Hauck has over 24 years of experience in various technical operations and management functions at Sanofi and its predecessor companies, which involved formulation development, plant management and global CMC leadership. He has demonstrated his ability to manage contract manufacturing organizations and to successfully develop alliances and collaborations with external partners.”
David Veitch – CEO, Basilea Pharmaceutica International Ltd.